ETHYL 4-((TERT-BUTYLDIMETHYLSILYL)OXY)BENZOATE, 95.0%, 500mg

N-(2-((5-Chloro-2-((2-methoxy-4-morpholinophenyl)amino)pyrimidin-4-yl)amino)phenyl)methanesulfonamide, 98%, 50mg

Methyl 2-bromo-3-methyl-3H-imidazo[4,5-b]pyridine-6-carboxylate, 95.0%, 1g

4,6-dimethyl-2-piperazin-1-yl-1,3-benzothiazole, 95.0%, 500mg

2-Methylanthracene, 97%, 100mg

3-Bromo-2-fluorobenzonitrile, 96.0%, 100g

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-phenylalanine>98.0%(HPLC)(T)5g

Dimolybdate d'ammonium, min 99%, pa, 500 g, emballage plastique.

Ethyl (2,6-Difluorophenyl)acetate, 97.0%, 1g

(Methyl(phenyl)amino)triphenylphosphonium iodide, 98%, 1g

Butyl Laurate>98.0%(GC)500mL

3-Bromo-5-(methoxycarbonyl)benzoic acid, 95.0%, 5g

2-(3-Methoxy-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg